Cargando…

Viral Diseases of the Liver

Viruses other than the classic hepatotropic viruses, hepatitis A through E, may cause hepatic injury [1]. Among these are Epstein–Barr virus (EBV), cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV), human herpes viruses (HHV) 6, 7, and 8, human parvovirus B19, and adeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lalazar, Gadi, Ilan, Yaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120377/ http://dx.doi.org/10.1007/978-3-319-02096-9_12

Ejemplares similares

Assessment of insulin resistance by a (13)C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients
por: Mizrahi, Meir, et al.
Publicado: (2010)

Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH
por: Mizrahi, Meir, et al.
Publicado: (2012)

Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury
por: Mizrahi, Meir, et al.
Publicado: (2018)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
por: Zigmond, Ehud, et al.
Publicado: (2014)

Mitral Stenosis Presenting with Acute Hearing Loss
por: Gur, Chamutal, et al.
Publicado: (2006)

An Interesting Case of Isolated False-Reactive Hepatitis B Surface Antigen
por: Costa, Victoria, et al.
Publicado: (2021)

Human liver organoids for disease modeling of fibrolamellar carcinoma
por: Narayan, Nicole J.C., et al.
Publicado: (2022)

Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA
por: Neumayer, Christoph, et al.
Publicado: (2023)

Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases
por: Ilan, Yaron
Publicado: (2022)

Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease
por: Ilan, Yaron
Publicado: (2016)

A continuous (13)C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
por: Lalazar, G, et al.
Publicado: (2008)

A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
por: Saltsman, James A., et al.
Publicado: (2020)

Alpha-1 Anti-trypsin Exerts a Hepatoprotective Effect on Immune-mediated Hepatitis and Acetaminophen-induced Liver Injury
por: Shabat, Yehudit, et al.
Publicado: (2018)

Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects
por: Ilan, Yaron
Publicado: (2020)

Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor
por: Ilan, Yaron
Publicado: (2021)

Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment
por: Ilan, Yaron
Publicado: (2018)

The constrained disorder principle defines living organisms and provides a method for correcting disturbed biological systems
por: Ilan, Yaron
Publicado: (2022)

Acute liver failure: a European perspective
por: Wendon, J, et al.
Publicado: (2010)

Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects
por: Khoury, Tawfik, et al.
Publicado: (2017)

Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?
por: Ilan, Yaron
Publicado: (2019)

Generating randomness: making the most out of disordering a false order into a real one
por: Ilan, Yaron
Publicado: (2019)

β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems
por: Ilan, Yaron
Publicado: (2019)

Order Through Disorder: The Characteristic Variability of Systems
por: Ilan, Yaron
Publicado: (2020)

Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes
por: Ilan, Yaron
Publicado: (2020)

Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
por: Ilan, Yaron
Publicado: (2022)

Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox
por: Ilan, Yaron
Publicado: (2021)

Impaired liver regeneration is associated with reduced cyclin B1 in natural killer T cell-deficient mice
por: Ben Ya’acov, Ami, et al.
Publicado: (2017)

The Constrained Disorder Principle Accounts for the Variability That Characterizes Breathing: A Method for Treating Chronic Respiratory Diseases and Improving Mechanical Ventilation
por: Adar, Ofek, et al.
Publicado: (2023)

Liver Disease Associated with Viral Infections
por: Spengler, Ulrich, et al.
Publicado: (2012)

Molecular Mechanism of Chronic Viral and Non-Viral Liver Diseases
por: Kanda, Tatsuo
Publicado: (2023)

Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent
por: Adar, Tomer, et al.
Publicado: (2022)

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
por: Eslam, Mohammed, et al.
Publicado: (2015)

The effect of medical students’ gender, ethnicity and attitude towards poetry-reading on the evaluation of a required, clinically-integrated poetry- based educational intervention
por: Muszkat, Mordechai, et al.
Publicado: (2014)

Viral Hepatitis and Liver Diseases in Mongolia
por: Baatarkhuu, Oidov, et al.
Publicado: (2017)

Non coding RNA analysis in fibrolamellar hepatocellular carcinoma
por: Farber, Benjamin A., et al.
Publicado: (2017)

The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy
por: Forkosh, Esther, et al.
Publicado: (2019)

Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies
por: Khoury, Tawfik, et al.
Publicado: (2019)

A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment
por: Kenig, Ariel, et al.
Publicado: (2019)

The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from “Nice to Have” to Mandatory Systems
por: Hurvitz, Noa, et al.
Publicado: (2023)

Using Constrained-Disorder Principle-Based Systems to Improve the Performance of Digital Twins in Biological Systems
por: Sigawi, Tal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jbvgdha9n1sspr306acakedv11